Austar Lifesciences Ltd.'s total assets for Q2 2025 were ¥2.03B, a decrease of -2.65% from the previous quarter. HK:6118 total liabilities were ¥1.22B for the fiscal quarter, a -5.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.